Zhou Done Joy, Ostertag-Hill Claire A, Ziegler Olivia, Vithiananthan Sivamainthan
The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Department of Surgery, Rhode Island Hospital/The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
J Surg Res. 2025 Jan;305:356-366. doi: 10.1016/j.jss.2024.11.029. Epub 2024 Dec 28.
Patients with end-stage renal disease (ESRD) are at increased risk for bleeding complications following surgery. However, the approach to the preoperative risk assessment and risk reduction, if feasible, in ESRD patients undergoing nonelective abdominal surgery has not been comprehensively studied. We aim to determine the prevalence and risk factors for perioperative bleeding in patients on dialysis undergoing nonelective abdominal surgery.
Using the American College of Surgeons National Surgical Quality Improvement Program 2005-2017 database, we identified patients on dialysis who underwent a variety of nonelective abdominal surgeries by Current Procedural Terminology code. Rates of major perioperative bleeding, defined as bleeding requiring red blood cell transfusion within 72 h after surgery, were calculated and stratified by procedure type. Multivariate logistic regression was used to identify risk factors for major perioperative bleeding. Thirty-day mortality rates were compared between those who had a major perioperative bleed and those who did not.
Of 9102 patients on dialysis undergoing nonelective abdominal surgery, 2793 (30.7%) experienced major perioperative bleeding requiring transfusion and 2002 (22.0%) died within 30 d of surgery. By multivariable logistic regression, patients who were female, independent or partially dependent in activities of daily living, ventilator dependent, had disseminated cancer, or had chronic steroid use at baseline were found to be at elevated risk for major perioperative bleeding. Elevated partial thromboplastin time, blood urea nitrogen, anemia, and hypoalbuminemia were also associated with higher odds of major bleeding. Compared to patients undergoing herniorrhaphy (lowest risk), the odds of major perioperative bleeding were highest for patients undergoing hepatic surgery (odds ratio [OR] = 18.09), splenic surgery (OR = 10.86), and pancreatic surgery (OR = 9.59). Major perioperative bleeding was associated with increased 30-d mortality (34.0% versus 16.7%, P < 0.001).
Patients with ESRD experience high rates of bleeding requiring transfusion following emergent abdominal surgery. Derangements in preoperative laboratories and baseline patient characteristics may be useful in assessing bleeding risk in this patient population.
终末期肾病(ESRD)患者术后出血并发症的风险增加。然而,对于接受非选择性腹部手术的ESRD患者,术前风险评估及可行的风险降低方法尚未得到全面研究。我们旨在确定接受非选择性腹部手术的透析患者围手术期出血的患病率及风险因素。
利用美国外科医师学会国家外科质量改进计划2005 - 2017年数据库,通过现行手术操作术语编码识别接受各种非选择性腹部手术的透析患者。计算围手术期大出血发生率(定义为术后72小时内需要输注红细胞的出血),并按手术类型分层。采用多因素逻辑回归分析确定围手术期大出血的风险因素。比较围手术期发生大出血患者与未发生大出血患者的30天死亡率。
在9102例接受非选择性腹部手术的透析患者中,2793例(30.7%)发生围手术期大出血需要输血,2002例(22.0%)在术后30天内死亡。多因素逻辑回归分析显示,女性、日常生活独立或部分依赖、依赖呼吸机、患有播散性癌症或基线时长期使用类固醇的患者围手术期大出血风险升高。活化部分凝血活酶时间延长、血尿素氮升高、贫血和低白蛋白血症也与大出血几率增加相关。与接受疝修补术的患者(风险最低)相比,接受肝脏手术的患者围手术期大出血几率最高(比值比[OR]=18.09),其次是脾脏手术(OR = 10.86)和胰腺手术(OR = 9.59)。围手术期大出血与30天死亡率增加相关(34.0%对16.7%,P<0.001)。
ESRD患者急诊腹部手术后出血需要输血的发生率很高。术前实验室检查异常及患者基线特征可能有助于评估该患者群体的出血风险。